About Ruth Gimeno

Ruth Gimeno, Ph.D., is Vice President, Diabetes Research and Clinical Investigation, at Eli Lilly and Company, in Indianapolis, Ind. She received undergraduate training in Medicine at the Julius-Maximilians-University in Würzburg, Germany, and obtained a Ph.D. in Biology from the Massachusetts Institute of Technology in Cambridge, Mass.

In 1996, Dr. Gimeno joined Millennium Pharmaceuticals in Cambridge, initially as a postdoctoral fellow and later as a staff scientist. In 2003, she moved to the metabolic disease group at Wyeth, later Pfizer, before joining Lilly in Indianapolis in 2011. In her current role, Dr. Gimeno is responsible for drug discovery and early clinical development of new therapies for diabetes and diabetic complications at Lilly.